- Preview Available
- Scholarly Journal
Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa
Nature Communications; London Vol. 16, Iss. 1, (2025): 3323.
DOI:10.1038/s41467-025-58597-6
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.